期刊文献+

亚临床型生殖器疱疹排毒与血清抗体检测及与药物治疗相关性研究 被引量:1

Research of the relations among the shedding of Subclinical genital herpes virus,serum antibodies test and drug therapies
下载PDF
导出
摘要 目的:探讨亚临床型生殖器疱疹患者的排毒与血清抗体检测及与药物治疗的相关性。方法:收集亚临床型生殖器疱疹患者,用分子生物学方法测定排毒质粒情况,及用酶联免疫法(ELISA)测定患者血清抗体(IgG和IgM)情况,以及和用药治疗后排毒情况。结果:入选病例300例中,排毒阳性160例,占53.3%;其中男性190例中,排毒阳性90例,占47.4%:女性110例中,排毒阳性70例,占63.6%。总的排毒质粒数最高值4.41×103Copies/ml,最低值80,平均910。血清学抗体HSV-l及HSV-2IgG和IgM检测,入选300例中,阳性201例,占67.0%。排毒阳性160例中,血清学阳性71例,占44.4%,排毒阴性140例中,阳性110例,占78.6%,二者阳性率有极显著性差异(χ2=36.48,P<0.01)。排毒阳性160例中,用药治疗后二组(伐昔洛韦片组和阿昔洛韦咀嚼片组)第5天、第10天及第4个月抑制排毒情况与对照组相比,均有显著性差异。结论:排毒阳性患者用药治疗后能明显抑制患者排毒率。 Objective: To study the relations among the shedding of subclinical genital herpes virus,serum antibodies test and drug therapy.Methods: Using FQ-PCR to test the shedding of subclinical genital herpes virus and using enzyme-linked immunosorbent assay(ELISA)to test the serum antibodies(Ig G and IgM) and studying the change of the shedding of subclnical genital herpes virus treated with drugs.Results: Among total 300 cases,160 cases(53.3%) were HSV shedding positive,90 cases (47.4%) were positive among male 190 cases and 70 cases(63.6 %) were positive among female 110 cases.The total results of shedding showed the number of DNA plasmids ranged from 80 copies/ml to 4.41×103 and the mean was 910 among 160 positive cases.There were 201 cases(67.0%) who were serum HSV antibodies(IgG and/or IgM)positive among total 300 cases,71 cases(44.4%)serum antibodies positive among 160 cases who were HSV shedding positive,and 110 cases(78.6%)serum positive among 140 cases who were HSV Shedding negative,which suggested there was significant difference of serum antibodies(χ^2=36.48,P〈0.01)between HSV Shedding positives and negatives.The results of controlling HSV shedding showed significant difference compared with control group after the treatment on 160 HSV shedding positives with Valaciclovir tablets(group one,65 cases) and Aciclovir Chewable tablets(group two,65 cases)for 5 days,10 days and four months.Conclusion: Drugs(treating groups)can obviously control HSV shedding.
出处 《华夏医学》 CAS 2010年第2期115-118,共4页 Acta Medicinae Sinica
基金 教育部"春晖计划"基金资助项目(Z2005-2-45004) 广西壮族自治区卫生厅计划课题资助项目(Z2004100)
关键词 亚临床型生殖疱疹排毒 荧光PCR检测 血清抗体检测 投服药物后抑制排毒 Subclinical GH virus shedding FQ-PCR Serum antibodies drugs controlling HSV shedding
  • 相关文献

参考文献13

二级参考文献58

  • 1张杰.单纯疱疹病毒与性传播[J].国外医学(流行病学.传染病学分册),1994,21(2):76-80. 被引量:6
  • 2钱起丰,李宇宁.单纯疱疹病毒2型血清IgG及IgM抗体的酶免疫检测[J].中华皮肤科杂志,1995,28(3):186-187. 被引量:7
  • 3Reyes M, Shaik NS, Graber JM, et al. Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics [J]. Arch Intern Med,2003, 163(1): 76-80.
  • 4Gershengorn HB, Darby G, Blower SM. Predicting the emergence of drug-resistant HSV-2: new predictions[J]. BMC Infect Dis,2003, 3(1): 1.
  • 5Pechere M, Wunderli W, Trellu-Toutous L, et al. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis[J]. Dermatology, 1998, 197(3): 278-280.
  • 6Chilukuri S, Rosen T. Management of acyclovir-resistant herpes simplex virus[J]. Dermatol Clin, 2003, 21(2): 311-320.
  • 7Tyring SK, Baker D, Snowden W. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir[J]. J Infect Dis, 2002, 186(Suppl 1): S40-46.
  • 8Bodsworth NJ, Crooks RJ, Borelli S, et al. Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study Group[J]. Genitourin Med, 1997, 73(2):110-116.
  • 9Mertz GJ, Loveless MO, Levin MJ, et al. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial.Collaborative Famciclovir Genital Herpes Research Group[J].Arch Intern Med, 1997, 157(3): 343-349.
  • 10Kroon S, Petersen CS, Andersen LP, et al. Long-term suppression of severe recurrent genital herpes simplex infections with oral acyclovir: a dose-titration study[J]. Genitourin Med, 1990,66(2): 101-104.

共引文献87

同被引文献14

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部